Anti-B3GNT9 antibodies are used in the immunodetection of the protein UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9. In humans, the canonical protein has a reported length of 402 amino acid residues and a mass of 43.8 kDa. Its subcellular localization is in the Golgi. It is notably widely expressed in many tissue types. It is a member of the Glycosyltransferase 31 protein family. Synonyms for this target antigen include beta-1,3-Gn-T9, beta-1,3-N-acetylglucosaminyltransferase 9, beta-1,3-galactosyltransferase-related protein, beta3Gn-T9, and BGnT-9. B3GNT9 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Indicated applications for B3gnt9 antibodies listed below include Immunocytochemistry, Immunofluorescence, and Immunohistochemistry.